Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Bain Capital Specialty Finance's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 0.00.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bain Capital Specialty Finance's liquidation value for the
three
months ended in Mar. 2026 was $-1,491.53 Mil.
Bain Capital Specialty Finance (NYSE:BCSF) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Bain Capital Specialty Finance's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:
2. In Ben Graham's calculation of liquidation value, Bain Capital Specialty Finance's accounts receivable are only considered to be worth 75% of book value:
Bain Capital Specialty Finance's liquidation value for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bain Capital Specialty Finance Change In Receivables Related Terms
Bain Capital Specialty Finance Change In Receivables Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bain Capital Specialty Finance Change In Receivables Chart
Bain Capital Specialty Finance Change In Receivables Calculation
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.87 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of $-2.87 Mil mean?
Bain Capital Specialty Finance (BCSF) has a Change In Receivables of $-2.87 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Bain Capital Specialty Finance and its competitors.
Is Bain Capital Specialty Finance's Change In Receivables too high?
Bain Capital Specialty Finance's current Change In Receivables is $-2.87 Mil. Overall, Bain Capital Specialty Finance has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bain Capital Specialty Finance's Change In Receivables compare to EOI and MFIC?
Bain Capital Specialty Finance's Change In Receivables of $-2.87 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for an Asset Management company?
A good Change In Receivables depends on the Asset Management industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Bain Capital Specialty Finance and its competitors. Bain Capital Specialty Finance's current Change In Receivables is $-2.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bain Capital Specialty Finance stock overvalued right now?
Based on GuruFocus' analysis, Bain Capital Specialty Finance (BCSF) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.20, compared to a current price of $12.82 — trading 25.7% above its estimated fair value. The current Change In Receivables is $-2.87 Mil. Bain Capital Specialty Finance's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Bain Capital Specialty Finance (BCSF), the current Change In Receivables is $-2.87 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bain Capital Specialty Finance (BCSF) Overvalued in 2026?
Based on GuruFocus' analysis, Bain Capital Specialty Finance stock appears to be overvalued.
The current stock price of $12.82 is trading 25.7% above its estimated GF Value™ of $10.20.
GuruFocus considers Bain Capital Specialty Finance to be Modestly Overvalued.
Key valuation signals for BCSF:
Change In Receivables: $-2.87 Mil
GF Value™: $10.20 vs. price of $12.82 (25.7% above fair value)
No single metric tells the full story. See the BCSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bain Capital Specialty Finance Business Description
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.
60GF Score
Get the complete analysis for BCSF
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCSF has been successfully added to your 
